After the Trump administration launched a broadside attack against the way the federal government has funded major research ...

The letters, many of which were already available online, detail why the regulators initially declined to approve some drugs.

Opinion How we plan to cut FDA drug approval time by months Qualifying manufacturers will be able to submit some data while clinical trials are ongoing.

One of the country's biggest food manufacturers is getting on board with Health Secretary RFK Jr.'s plans to stop the industry from using synthetic dyes. FDA Commissioner Dr. Marty Makary joins ...

All the figurative FDA trains are running on time, according to the agency’s leader Marty Makary, M.D. | “I'm proud to report that we're on track to meet all the PDUFA targets, and that morale ...

Food and Drug Administration Commissioner Marty Makary said the agency will aim to review select drugs in one to two months. FDA’s long-standing accelerated approval program generally issues decisions ...

FDA Commissioner Marty Makary faces declining staff morale as he remakes the agency.

FDA Commissioner Marty Makary faces declining staff morale as he remakes the agency.

According to an internal email, the agency may be in for more consolidation in areas including human resources, communications, travel and acquisitions. FDA Commissioner Marty Makary is considering ...